Phase 2 Studies of Novel JAK1 Inhibitor for HS Show Promise Phase 2 Studies of Novel JAK1 Inhibitor for HS Show Promise
Results of the two phase 2 studies"establish proof of concept" for the JAK1 inhibitor for the treatment of moderate to severe hidradenitis suppurativa, the investigators concluded.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - January 24, 2022 Category: Dermatology Tags: Dermatology News Source Type: news

More Than a Month After Launch, iPLEDGE Glitches Persist More Than a Month After Launch, iPLEDGE Glitches Persist
The latest improvement attempt is a tool created by the Isotretinoin Products Manufacturers Group (IPMG), the manufacturers responsible for the FDA-mandated REMS program.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - January 22, 2022 Category: Dermatology Tags: Dermatology News Source Type: news

Antibiotic Choices for Inpatients With SSTIs Vary by Race Antibiotic Choices for Inpatients With SSTIs Vary by Race
' To see such racial differences play out in acute care is striking,'said one of the authors of a national, cross-sectional study involving more than 1000 patients across 91 hospitals.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - January 20, 2022 Category: Dermatology Tags: Dermatology News Source Type: news

Dermatologic Use of Medical Cannabis Use Lags Behind Interest Dermatologic Use of Medical Cannabis Use Lags Behind Interest
The most common indication among the respondents with dermatologist recommendations for products requiring a medical card was for acne (68%), followed by psoriasis and rosacea (28% each).Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - January 20, 2022 Category: Dermatology Tags: Dermatology News Source Type: news

New Antifungal Medications Are Sorely Needed New Antifungal Medications Are Sorely Needed
Better treatment for Candida auris, Aspergillus and other dangerous fungal pathogens is slow to come, even as rates of drug resistance rise. New therapies are in the pipeline, and hospital practices can help.Knowable Magazine (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - January 20, 2022 Category: Dermatology Tags: Infectious Diseases News Source Type: news

ILD Screening in Rheumatic Diseases: Strategies to Consider ILD Screening in Rheumatic Diseases: Strategies to Consider
Two experts from Hospital for Special Surgery review the current landscape and evidence for interstitial lung disease screening in patients with connective tissue diseases.Medscape Rheumatology (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - January 19, 2022 Category: Dermatology Tags: Rheumatology Commentary Source Type: news

Sorting Out Sleep Complaints in Children With AD Can Be Complex Sorting Out Sleep Complaints in Children With AD Can Be Complex
An estimated 50% of children with atopic dermatitis struggle with sleep problems.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - January 12, 2022 Category: Dermatology Tags: Dermatology News Source Type: news

Ask These Key Questions About Atopic Dermatitis Sleep Problems Ask These Key Questions About Atopic Dermatitis Sleep Problems
Assessment tools to consider are the Epworth Sleepiness Scale, the Insomnia Severity Index, and the STOP-Bang questionnaire.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - January 9, 2022 Category: Dermatology Tags: Dermatology News Source Type: news

Hair Loss on the Presidential Ballot in South Korea Hair Loss on the Presidential Ballot in South Korea
A presidential candidate's new proposal has gained support for his campaign — particularly among bald men.Quick Take (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - January 7, 2022 Category: Dermatology Tags: Internal Medicine News Source Type: news

Atopic Dermatitis' Longitudinal Course Often Gets Overlooked Atopic Dermatitis' Longitudinal Course Often Gets Overlooked
"Understanding the long-term course may improve our ability to phenotype, prognosticate, and personalize our care," Raj Chovatiya, MD, PhD, said.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - January 6, 2022 Category: Dermatology Tags: Dermatology News Source Type: news

Itch-Dominant Atopic Dermatitis Often Flies Under the Radar Itch-Dominant Atopic Dermatitis Often Flies Under the Radar
A disconnect often exists between clinician-reported and patient-reported outcome measures, said Jonathan Silverberg.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - January 5, 2022 Category: Dermatology Tags: Dermatology News Source Type: news

Case Series Show No Consensus on Treatment for Palmoplantar Pustulosis, Generalized Pustular Psoriasis Case Series Show No Consensus on Treatment for Palmoplantar Pustulosis, Generalized Pustular Psoriasis
"These case series confirm the rarity of both generalized pustular psoriasis and palmoplantar pustulosis...and the lack of effective treatment options," the lead author said.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - January 4, 2022 Category: Dermatology Tags: Dermatology News Source Type: news

Atopic Dermatitis Can Be Especially Burdensome in the Elderly Atopic Dermatitis Can Be Especially Burdensome in the Elderly
There is informative data on higher relative risk of osteoporosis/fractures and dementia, specifically among older adults with atopic dermatitis.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - January 4, 2022 Category: Dermatology Tags: Dermatology News Source Type: news

FDA to Review Topical PDE4-Inhibitor Roflumilast for Psoriasis FDA to Review Topical PDE4-Inhibitor Roflumilast for Psoriasis
In an open label phase 2b study of roflumilast, the treatment effect lasted for 52-64 weeks, according to the manufacturer.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - December 30, 2021 Category: Dermatology Tags: Dermatology News Source Type: news

FDA Approves Tralokinumab for Moderate to Severe AD FDA Approves Tralokinumab for Moderate to Severe AD
Tralokinumab is a fully human IgG4 monoclonal antibody that specifically binds to interleukin-13, a key driver of underlying inflammation in AD.FDA Approvals (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - December 28, 2021 Category: Dermatology Tags: Dermatology News Alert Source Type: news

Is It OK to Just Be Satisfied? Is It OK to Just Be Satisfied?
Being a'satisficer'or maximizer is probably somewhat fixed, a personality trait, like being extroverted or conscientious, Dr Jeffrey Benabio writes.Medscape Dermatology (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - December 28, 2021 Category: Dermatology Tags: Dermatology Commentary Source Type: news

Does Atopic Dermatitis Pose an Increased Risk of Acquiring COVID-19? Does Atopic Dermatitis Pose an Increased Risk of Acquiring COVID-19?
' This is an area that will continue to evolve, and further understanding will improve the healthcare advice that we provide to our patients,'Dr Jacob P. Thyssen said.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - December 28, 2021 Category: Dermatology Tags: Dermatology News Source Type: news

iPLEDGE Rollout: As Frustration Mounts, FDA Agrees to Help iPLEDGE Rollout: As Frustration Mounts, FDA Agrees to Help
At a meeting with the FDA, AADA representatives described the severe impact on patient access to treatment that is resulting from the issues with the iPLEDGE rollout.News Alerts (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - December 22, 2021 Category: Dermatology Tags: Dermatology News Source Type: news

Low-Power Laser and an Injectable in One Session: Is It Safe? Low-Power Laser and an Injectable in One Session: Is It Safe?
To date, limited studies have demonstrated the safety of pairing botulinum neurotoxin type A and soft-tissue fillers with laser and other energy-based devices during the same treatment session.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - December 22, 2021 Category: Dermatology Tags: Dermatology News Source Type: news

Proactive Infliximab Monitoring Best Sustains Disease Control Proactive Infliximab Monitoring Best Sustains Disease Control
Proactive therapeutic drug monitoring with maintenance infliximab proved more effective in sustaining disease control than did standard care in patients with immune-mediated inflammatory diseases.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - December 21, 2021 Category: Dermatology Tags: Rheumatology News Source Type: news

Biologic for Rare Form of Psoriasis Under FDA Priority Review Biologic for Rare Form of Psoriasis Under FDA Priority Review
The indication under review for spesolimab, an interleukin-36 receptor antagonist, is for the treatment of flares in patients with generalized pustular psoriasis.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - December 17, 2021 Category: Dermatology Tags: Dermatology News Source Type: news

AD Severity Linked to More Frequent Bathing, Not Duration AD Severity Linked to More Frequent Bathing, Not Duration
Current guidelines on bathing frequency and duration among AD patients lack consensus, are limited, and are largely based on studies of pediatric populations.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - December 16, 2021 Category: Dermatology Tags: Dermatology News Source Type: news

FDA Approves Upadacitinib (Rinvoq) for Psoriatic Arthritis FDA Approves Upadacitinib (Rinvoq) for Psoriatic Arthritis
The approval of upadacitinib 15 mg for adults with psoriatic arthritis is the second indication for the JAK inhibitor after it was first approved for rheumatoid arthritis in 2019.FDA Approvals (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - December 15, 2021 Category: Dermatology Tags: Rheumatology News Alert Source Type: news

Abrocitinib Efficacy Dose-Dependent, Similar Across AD Age Groups Abrocitinib Efficacy Dose-Dependent, Similar Across AD Age Groups
As for adverse events, nausea was more frequent in patients aged 12-17 and aged 18-40 years than it was for those age 51 or older.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - December 15, 2021 Category: Dermatology Tags: Dermatology News Source Type: news

Abrocitinib Approved for Atopic Dermatitis in Europe Abrocitinib Approved for Atopic Dermatitis in Europe
The oral JAK inhibitor was approved for treating AD earlier in 2021 for treating AD in the United Kingdom, Japan, and Korea, and is under review at the US Food and Drug Administration.FDA Approvals (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - December 13, 2021 Category: Dermatology Tags: Dermatology News Alert Source Type: news

Dermatologists Take to TikTok to Share Their Own'Hacks'Dermatologists Take to TikTok to Share Their Own'Hacks '
Millions get skin care advice from TikTok, but it's rarely from board-certified dermatologists.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - December 11, 2021 Category: Dermatology Tags: Dermatology News Source Type: news

Adding Microneedling to Topical Treatments Effective Adding Microneedling to Topical Treatments Effective
Adding topical therapies to microneedling resulted in greater improvements in melasma severity, with improved patient-reported satisfaction and quality of life.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - December 9, 2021 Category: Dermatology Tags: Dermatology News Source Type: news

Melasma: Adding Microneedling to Topical Treatments Effective Melasma: Adding Microneedling to Topical Treatments Effective
Adding topical therapies to microneedling resulted in greater improvements in melasma severity, with improved patient-reported satisfaction and quality of life.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - December 9, 2021 Category: Dermatology Tags: Dermatology News Source Type: news

Closing Your Practice: What You Need to Know Closing Your Practice: What You Need to Know
"This cannot (and should not) be a hasty process. You will need at least a year to do it correctly, because there is a lot to do," advises Joseph Eastern, MD.Medscape Dermatology (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - December 9, 2021 Category: Dermatology Tags: Dermatology Commentary Source Type: news

Atopic Dermatitis: Expert Shares Parents' Top Five Questions Atopic Dermatitis: Expert Shares Parents' Top Five Questions
Whether a child will outgrow eczema and the role of allergies are among the most common questions from parents.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - December 9, 2021 Category: Dermatology Tags: Dermatology News Source Type: news

Panel Recommends Energy-Based Devices as Treatment of Acne Scars Panel Recommends Energy-Based Devices as Treatment of Acne Scars
Panel suggests that laser resurfacing does not have to be delayed at least 6 months post isotretinoin in acne patients.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - December 6, 2021 Category: Dermatology Tags: Dermatology News Source Type: news

Guselkumab Deemed Effective for PsA Previously Treated With TNFi Guselkumab Deemed Effective for PsA Previously Treated With TNFi
COSMOS trial results in patients with psoriatic arthritis fit with the expectation that"people who've previously failed a TNF inhibitor might be a little less likely to respond to guselkumab."Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - December 2, 2021 Category: Dermatology Tags: Rheumatology News Source Type: news

The Connection Between Psoriasis and Depression: What You Need To Know The Connection Between Psoriasis and Depression: What You Need To Know
Dr Richard Fried discusses psoriasis, its relationship with depression, and how to address symptoms to improve patients ’ quality of life.Medscape Dermatology (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - December 2, 2021 Category: Dermatology Tags: Dermatology Commentary Source Type: news

Novel Plasma Gas-Based Strategy Kills Resistant Bacteria Novel Plasma Gas-Based Strategy Kills Resistant Bacteria
The antibiotic-free formulation shows potential as a targeted treatment for antimicrobial-resistant bacteria in chronic wounds such as diabetic foot ulcers, as well as a potential therapy for SARS-CoV-2.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - November 30, 2021 Category: Dermatology Tags: Infectious Diseases News Source Type: news

Obesity or Psoriasis: What Comes First? Obesity or Psoriasis: What Comes First?
Many psoriasis patients present with associated comorbidities such as obesity, and while the former is not currently deemed a risk factor for COVID-19, adiposity is.Medscape Diabetes & Endocrinology (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - November 24, 2021 Category: Dermatology Tags: Dermatology Commentary Source Type: news

Words From the Wise Words From the Wise
When there's time, consider asking for advice from those elders who happen to have an appointment with you. Bring you wisdom, they will.Medscape Dermatology (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - November 23, 2021 Category: Dermatology Tags: Dermatology Commentary Source Type: news

Embezzlement: It Can Happen to You Embezzlement: It Can Happen to You
The office manager of a San Antonio, Texas, dermatology practice was recently sentenced to 46 months in prison for defrauding the practice of nearly $350,000.Medscape Dermatology (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - November 17, 2021 Category: Dermatology Tags: Dermatology Commentary Source Type: news

Adding Rituximab to Belimumab Offers No Help for Lupus Adding Rituximab to Belimumab Offers No Help for Lupus
The combination of rituximab and belimumab was associated with a longer duration of response, but there was no benefit of belimumab alone for disease control at 1 year.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - November 15, 2021 Category: Dermatology Tags: Rheumatology News Source Type: news

Typical Contact Dermatitis Screening Misses Many Allergens Typical Contact Dermatitis Screening Misses Many Allergens
Adding allergens to screening beyond the typical series, especially those found in personal care products and workplace substances, is key to diagnosing and managing the disease, authors say.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - November 12, 2021 Category: Dermatology Tags: Allergy & Clinical Immunology News Source Type: news

From Cows to COVID: The Spooky Origins of Vaccines From Cows to COVID: The Spooky Origins of Vaccines
Like many life-saving innovations in medicine, vaccination emerged long before we understood how it worked.Undark (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - November 12, 2021 Category: Dermatology Tags: Infectious Diseases News Source Type: news

' Foot Selfies' May Improve Remote Diabetic Foot Monitoring'Foot Selfies' May Improve Remote Diabetic Foot Monitoring
Device that uses a foot platform and voice-command smartphone app allows patients to take and digitally transmit photos of the bottoms of their feet.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - November 11, 2021 Category: Dermatology Tags: Diabetes & Endocrinology News Source Type: news

Striae Gravidarum: More than a'Nuisance,' Say Researchers Striae Gravidarum: More than a'Nuisance,' Say Researchers
The authors suggest that healthcare practitioners not think of striae gravidarum as merely a cosmetic"nuisance."Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - November 11, 2021 Category: Dermatology Tags: Dermatology News Source Type: news

Contact Allergens in Medical Devices: A Cause for Concern? Contact Allergens in Medical Devices: A Cause for Concern?
The findings, described as'alarming'by one allergist, suggest that more scrutiny may be necessary on medical device labels, many of which do not currently require listing of potential skin sensitizers.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - November 9, 2021 Category: Dermatology Tags: Allergy & Clinical Immunology News Source Type: news

Multiple Features Lead to a Diagnosis of Hyperhidrosis Multiple Features Lead to a Diagnosis of Hyperhidrosis
The prevalence is as high as 4.8%, which means that nearly 10 million Americans have hyperhidrosis.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - November 9, 2021 Category: Dermatology Tags: Dermatology News Source Type: news

Factors for PAs to Consider When Contemplating an Advanced Degree Factors for PAs to Consider When Contemplating an Advanced Degree
The most common doctoral degree that PAs are seeking now is the Doctor of Medical Science.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - November 8, 2021 Category: Dermatology Tags: Dermatology News Source Type: news

Risankizumab Outperforms Placebo at 6 Months for Psoriatic Arthritis Risankizumab Outperforms Placebo at 6 Months for Psoriatic Arthritis
At the 24-week assessment, participants receiving risankizumab showed greater improvement in primary and secondary endpoints than did placebo with no new safety signals.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - November 8, 2021 Category: Dermatology Tags: Rheumatology News Source Type: news

Rituximab Improves Systemic Sclerosis Skin, Lung Symptoms Rituximab Improves Systemic Sclerosis Skin, Lung Symptoms
Patients who took rituximab in the DESIRES trial had better skin scores and lung function at 6 months than did patients who received placebo.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - November 8, 2021 Category: Dermatology Tags: Rheumatology News Source Type: news

JAK Inhibitors Expand Biologic Options for Atopic Dermatitis JAK Inhibitors Expand Biologic Options for Atopic Dermatitis
JAK inhibitors expand biologic possibilities beyond tried-and-true dupilumab, but uptake may be slowed by safety concerns.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - November 8, 2021 Category: Dermatology Tags: Allergy & Clinical Immunology News Source Type: news

Three Signs Point to a Diagnosis of Psoriatic Arthritis Three Signs Point to a Diagnosis of Psoriatic Arthritis
Dactylitis, an inflamed sausage-like finger or toe, is a classic finding of psoriatic arthritis.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - November 7, 2021 Category: Dermatology Tags: Dermatology News Source Type: news

Psoriasis: Treating to Target, How Do You Get There? Psoriasis: Treating to Target, How Do You Get There?
"With currently available treatment options, achieving complete or almost complete skin clearance is a very realistic outcome."Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - November 6, 2021 Category: Dermatology Tags: Dermatology News Source Type: news